BergaMet Pro Studies | BergaMet North America

.product_section .product_form, .product_gallery { opacity: 1; } .multi_select, form .select { display: block !important; } .image-element__wrap { display: none; }

Click on Link to View

Characterization of flavonoids in Citrus bergamia (Bergamot) polyphenolic fraction by liquid chromatography-high resolution mass spectrometry (LC/HRMS)
Molecular mechanisms of lipid-and glucose-lowering activities of bergamot flavonoids
Studies on the protective role of Bergamot polyphenols in doxorubicin-induced cardiotoxicity
The effect of bergamot polyphenolic fraction in patients with non alcoholic liver steato-hepatitis and metabolic syndrome
Bergamot polyphenolic fraction counteracts photoaging in human keratinocytes
The protective role of bergamot polyphenolic fraction on several animal models of pain
Bergamot Polyphenolic Fraction Counteracts Erectile Dysfunction Occurring in Patients Suffering From Type 2 Diabetes
Citrus Bergamot Improves Atherogenic Lipoprotein Particle Characteristics in Patients with Non-alcoholic Fatty Liver Disease and Metabolic Syndrome

The Hepatic Effects of Citrus Bergamot Polyphenolic Fraction (BPF) on Patients with Non-alcoholic Fatty Liver Disease and Metabolic Syndrome

10Bergamot Polyphenol Fraction Prevents Non Alcoholic Fatty Liver Disease via Stimulation of Lipophagy in Cafeteria Diet-Induced Rat Model of Metobolic Syndrome

Telomere and Telomerase Modulation by Bergamot Polyphenolic Fraction in Experimental Photoageing in Human Keratinocytes

Mechanisms Underlying the Anti-Tumoral Effects of Citrus bergamia Juice

Hypolipemic and Hypoglycaemic Activity of Bergamot Polyphenols: From Animal Models to Human Studies

The Use of Bergamot Derived Polyphenolic Fraction in Cardiometabolic Risk Prevention and its possible Mechanisms of Action

Use of a Novel and Natural Antioxidant Compound (Bergamot) in the Management of Statine Intolerance